BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 13469072)

  • 1. Fluctuability of steroid excretion.
    ZONDEK H; ZONDEK GW; LESZYNSKY HE
    Acta Endocrinol (Copenh); 1957 Sep; 26(1):91-5. PubMed ID: 13469072
    [No Abstract]   [Full Text] [Related]  

  • 2. Urinary 17-keto-steroid and 17-ketogenic steroid excretion in Cushing's syndrome.
    HEIDER CH; HANDLEY CA; FORD RV
    J Clin Endocrinol Metab; 1959 Nov; 19():1471-6. PubMed ID: 14400611
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of corticotropin and 9alpha-fluorohydrocortisone on urinary steroids in Cushing's syndrome.
    JENKINS JS; SPENCE AW
    J Clin Endocrinol Metab; 1957 May; 17(5):621-31. PubMed ID: 13416372
    [No Abstract]   [Full Text] [Related]  

  • 4. [Content of steroids in the urine in Addison's disease and Itsenko-Cushing syndrome after ACTH administration].
    KHARVAT I; KANDRACH MSh
    Klin Med (Mosk); 1959 Jun; 37(6):51-61. PubMed ID: 13673498
    [No Abstract]   [Full Text] [Related]  

  • 5. [Determination of urinary steroids in adrenocortical hyperfunction].
    JAKOBSON T
    Duodecim; 1959; 75():808-17. PubMed ID: 13853081
    [No Abstract]   [Full Text] [Related]  

  • 6. Urinary corticosteroid excretion patterns in patients with adrenocortical dysfunction.
    DYRENFURTH I; SYBULSKI S; NOTCHEV V; BECK JC; VENNING EH
    J Clin Endocrinol Metab; 1958 Apr; 18(4):391-408. PubMed ID: 13513739
    [No Abstract]   [Full Text] [Related]  

  • 7. Variations in urine excretion of steroid hormones after an acute session and after a 4-week programme of strength training.
    Timón Andrada R; Maynar Mariño M; Muñoz Marín D; Olcina Camacho GJ; Caballero MJ; Maynar Mariño JI
    Eur J Appl Physiol; 2007 Jan; 99(1):65-71. PubMed ID: 17051372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Study of the urinary excretion of alpha-ketolic corticoids and aldosterone during Cushing's syndrome].
    ROMANI JD; ALBEAUX-FERNET M; CHABOT J
    Rev Med Fr; 1961 Jan; 42():15-6. PubMed ID: 24545746
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diurnal variation of 17-OHCS and 17-KS in adreno-cortical diseases, particularly in Cushing's syndrome].
    HIROSE K
    Nihon Hinyokika Gakkai Zasshi; 1962 Jun; 53():448-55. PubMed ID: 13907666
    [No Abstract]   [Full Text] [Related]  

  • 10. [The excretion of various steroid metabolites in pathologic adrenal cortex function].
    Teller W
    Monatsschr Kinderheilkd (1902); 1967 Apr; 115(4):314-6. PubMed ID: 5592546
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of blood, chorionic & hypophyseal gonadotropins on the urinary excretion of estrogens, 17-ketosteroids & reducing corticoids; researches in normal persons.
    SUARDI L
    Riforma Med; 1957 Sep; 71(36):1007-16. PubMed ID: 13495119
    [No Abstract]   [Full Text] [Related]  

  • 12. [Studies on the steroid excretion in a patient with a Cushing syndrome associated with a secondary myxedema due to hypophyseal tumor].
    Kleinfelder H; Husmann F
    Arch Klin Med; 1966; 212(2):129-42. PubMed ID: 4292111
    [No Abstract]   [Full Text] [Related]  

  • 13. Urinary 6 beta-hydroxy-cortisol in adrenocortical hyperfunction.
    TOUCHSTONE JC; BLAKEMORE WS
    J Clin Endocrinol Metab; 1961 Mar; 21():263-70. PubMed ID: 13777691
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies in Cushing's syndrome. III. Urinary 17-ketosteroids in patients with bilateral adrenal cortical hyperplasia.
    JAILER JW; VANDE WIELE R; CHRISTY NP; LIEBERMAN S
    J Clin Invest; 1959 Feb; 38(2):357-65. PubMed ID: 13631067
    [No Abstract]   [Full Text] [Related]  

  • 15. [Two cases of hypercorticalism: value of urinary examinations for polysteroids].
    AZERAD ; BEAULIEU ; JAYLE
    Bull Mem Soc Med Hop Paris; 1953 Jun 26-Jul 10; 69(21-3):726-33. PubMed ID: 13094525
    [No Abstract]   [Full Text] [Related]  

  • 16. Diurnal variation of 17-hydroxycorticosteroids, sodium, potassium, magnesium and creatinine in normal subjects and in cases of treated adrenal insufficiency and Cushing's syndrome.
    DOE RP; VENNES JA; FLINK EB
    J Clin Endocrinol Metab; 1960 Feb; 20():253-65. PubMed ID: 13817162
    [No Abstract]   [Full Text] [Related]  

  • 17. [Action of magnesium p-aminobenzoate and of fluosilicic acid on the urinary elimination of steroid hormones].
    NEUKOMM S
    Arch Int Pharmacodyn Ther; 1955 Jul; 102(3):359-64. PubMed ID: 13239274
    [No Abstract]   [Full Text] [Related]  

  • 18. [Persistence of an adrenal-type steroid elimination following total bilateral adrenalectomy for Cushing's disease].
    BRICAIRE H; TOURNEUR R; LAUDAT P; VIGNERON P
    Rev Fr Endocrinol Clin; 1961; 2():469-80. PubMed ID: 13873004
    [No Abstract]   [Full Text] [Related]  

  • 19. [The corticotropin stimulus test by venous route in Cushings's syndrome].
    LOTTI P; IACOBELLI A; SORCINI G; MONTERVINO C; SCIARRA F; GIOVANNINI C
    Folia Endocrinol Mens Incretologia Incretoterapia; 1960 Dec; 13():833-45. PubMed ID: 13763647
    [No Abstract]   [Full Text] [Related]  

  • 20. [Urinary elimination of 17-ketosteroids and corticoids in subjects with adrenal cortical hyperfunction treated with roentgenotherapy].
    SILVESTRINI F; PASARGIKLIAN E; BONELLI M
    Folia Endocrinol Mens Incretologia Incretoterapia; 1953 Dec; 6(6):899-908. PubMed ID: 13151226
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.